Array Biopharma Inc

CIK 1100412 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Array Biopharma Inc.

Recent SEC filings

FiledFormAccession number
Feb 14, 2020SC 13G/A0001104659-20-021810
Aug 12, 2019SC 13G/A0000315066-19-001673
Aug 9, 201915-12B0001193125-19-217516
Jul 31, 2019EFFECT9999999995-19-001738
Jul 31, 2019EFFECT9999999995-19-001747
Jul 31, 2019EFFECT9999999995-19-001774
Jul 31, 2019EFFECT9999999995-19-001746
Jul 31, 2019EFFECT9999999995-19-001741
Jul 31, 2019EFFECT9999999995-19-001740
Jul 31, 2019EFFECT9999999995-19-001743
Jul 31, 2019EFFECT9999999995-19-001742
Jul 31, 2019EFFECT9999999995-19-001739
Jul 31, 2019EFFECT9999999995-19-001745
Jul 31, 2019EFFECT9999999995-19-001744
Jul 31, 2019EFFECT9999999995-19-001737
Jul 30, 2019S-8 POS0001193125-19-206291
Jul 30, 20198-K0001193125-19-206255
Jul 30, 201940001209191-19-043776
Jul 30, 2019SC 14D9/A0001193125-19-206253
Jul 30, 2019S-8 POS0001193125-19-206304
Jul 30, 2019S-8 POS0001193125-19-206305
Jul 30, 2019POS AM0001193125-19-206286
Jul 30, 2019S-8 POS0001193125-19-206302
Jul 30, 2019POS AM0001193125-19-206270
Jul 30, 2019POS AM0001193125-19-206274